One major area in enabling equitable access to cancer treatment and screening, is the harmonization of resources to push the boundaries of collaborative R&D. Our R&D partnering program allows for cutting-edge technology to be developed and deployed by leveraging infrastructure and resources available in developing nations such as India.  By reducing overheads and enhancing efficiency, it enables biotech companies to price products more affordably or obtain insights for differential pricing in varied geographies and provide effective therapeutic strategies. In doing so, many more patients might avail more reasonably priced solutions and transform patient care.